Tirofiban plus sirolimus-eluting stent vs abciximab plus bare-metal stent

JAMA. 2005 Oct 5;294(13):1617; author reply 1617-8. doi: 10.1001/jama.294.13.1617-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Drug Delivery Systems
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Immunosuppressive Agents / administration & dosage*
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / agonists*
  • Sirolimus / administration & dosage*
  • Stents*
  • Thrombectomy*
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Tirofiban
  • Sirolimus
  • Abciximab